Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12608000547347
Ethics application status
Approved
Date submitted
16/09/2008
Date registered
29/10/2008
Date last updated
8/08/2012
Type of registration
Retrospectively registered

Titles & IDs
Public title
The assessment of blinding: the case of caffeinated and de-caffeinated coffee
Scientific title
Can healthy individuals detect the replacement of caffeinated coffee with decaffeinated coffee
Secondary ID [1] 280992 0
New secondary ID. Please modify.
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
removal of coffee from diet 3701 0
Condition category
Condition code
Other 3865 3865 0 0
Research that is not of generic health relevance and not applicable to specific health categories listed above
Public Health 4036 4036 0 0
Epidemiology

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Replacing regular coffee with supplied decaffeinated coffee for 1 week. As per inclusion criteria, participants should consume at least 2 cups per day, but no set requirement to consume a specified amount. Both Caffeinated and Decaffeinated coffee will be supplied by The Coffee Roaster.
Intervention code [1] 3571 0
Lifestyle
Comparator / control treatment
Replacing regular coffee with supplied caffeinated coffee for 1 week. As per inclusion criteria, participants should consume at least 2 cups per day, but no set requirement to consume a specified amount. Both Caffeinated and Decaffeinated coffee will be supplied by The Coffee Roaster.
Control group
Active

Outcomes
Primary outcome [1] 4767 0
Assessment of blinding using self completed questionnaires, asking "what type of coffee do you think you are drinking"
Timepoint [1] 4767 0
Day 1, day 3 and day 7
Secondary outcome [1] 8054 0
Assess what factors lead to unblinding using self completed questionnaires asking "why do you think you are drinking this type of coffee?"
Timepoint [1] 8054 0
Day 1, Day 3 and Day7

Eligibility
Key inclusion criteria
18 years or older, Drink at least 2 cups of caffeinated coffee per day, ability to personally collect coffee from research staff, have internet access
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
people will be excluded if they do not meet inclusion criteria

Study design
Purpose of the study
Educational / counselling / training
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Participants register online, once eligible will be allocated to the next intervetion group as per randomisation schedule. This schedule will be concealed from investigators until allocation is required using sealed opaque envelopes.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
computer generated block randomisation.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
1/10/2008
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
150
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 3879 0
Charities/Societies/Foundations
Name [1] 3879 0
Australian Federation of University Women River Group
Country [1] 3879 0
Australia
Primary sponsor type
Individual
Name
A/Prof Alex Barratt
Address
Edward Ford Building (A27)
University of Sydney
NSW 2006
Country
Australia
Secondary sponsor category [1] 3483 0
Individual
Name [1] 3483 0
A/Prof Rob Herbert
Address [1] 3483 0
The George Institute
PO Box M201
Missenden Rd,
Camperdown NSW 2050
Country [1] 3483 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 5931 0
University of Sydney Human Research Ethics Committee
Ethics committee address [1] 5931 0
Ethics committee country [1] 5931 0
Australia
Date submitted for ethics approval [1] 5931 0
Approval date [1] 5931 0
Ethics approval number [1] 5931 0
11117

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 28939 0
Address 28939 0
Country 28939 0
Phone 28939 0
Fax 28939 0
Email 28939 0
Contact person for public queries
Name 12096 0
Erin Mathieu
Address 12096 0
Edward Ford Building (A27)
The University of Sydney, NSW 2006
Country 12096 0
Australia
Phone 12096 0
0293515112
Fax 12096 0
Email 12096 0
e.mathieu@uws.edu.au
Contact person for scientific queries
Name 3024 0
Erin Mathieu
Address 3024 0
Edward Ford Building (A27)
The University of Sydney, NSW 2006
Country 3024 0
Australia
Phone 3024 0
0293515112
Fax 3024 0
Email 3024 0
e.mathieu@uws.edu.au

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.